Hundreds of Australians living with dementia remain stranded in public hospital beds due to a chronic shortage of aged care ...

A new review of preclinical studies suggests GLP-1 drugs like Ozempic may reduce key proteins linked to Alzheimer’s disease.

The Food and Drug Administration (FDA) approved the drug Auvelity this week for the treatment of agitation in adults with ...

Axsome Therapeutics (AXSM 0.59%) has been growing sales rapidly with its Auvelity antidepressant. The biopharmaceutical ...

In this study roundup, Medical News Today compiles the latest evidence on the benefits of Vitamin D, focusing on the key ...

THE use of rapid tranquilisation being used to sedate dementia patients over the past year is “nice and low”, the Health Department has said – a year after major concerns were raised by charity ...

(Olga Pankova/Moment/Getty Images) Nutritional supplements are exploding in popularity, but some experts remain skeptical of ...

Care at home often lacks the clinical leadership and structure necessary to be safe, consistent, and sustainable.

Menopause happens to every woman, and it may hold clues as to why women are at a greater risk for Alzheimer’s disease. Yale ...

Social media influencers have been making bold claims that GLP-1 medications — the same drugs used for weight loss and ...

A new study shows that changes linked to Alzheimer’s disease can speed up with age in people’s late 50s, long before memory ...

Clips from 30/04/2026 ...